CoV-2 virus, we're still learning about its complications, with the latest research suggesting that long covid may disrupt ...

There are now numerous cases of long-lasting aftereffects of a COVID-19 infection. These are referred to as long COVID ...

Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in ...

Researchers have found in a new study that azelastine nasal spray may help reduce the risk of SARS-CoV-2 infection.

Alcohol use disorder (AUD) and alcohol consumption are associated with worse COVID-19 outcomes, according to study findings published in Chest.

Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

Moderna (MRNA) announced “positive” preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

In maintenance hemodialysis (MHD) patients infected with SARS-CoV-2, various thromboembolic complications have been reported, ...

JN.1-adapted COVID-19 vaccines were effective against hospitalization and mortality for at least 4 months among older adults.

These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer ...